You are here: Industry Insights > Skin cancer

News List

NICE nod for Novartis’ targeted skin cancer combo pharmatimes
September 18, 2018
The National Institute for Health and Care Excellence has backed NHS funding for Novartis’ oral targeted adjuvant combination therapy...
Merck gets Chinese approval for Keytruda to treat skin cancer pharmaceutical-technology
July 31, 2018
Merck has secured approval from the China National Drug Administration (CNDA) for the use of its Keytruda medicine to treat adults suffering from unresectable or metastatic melanoma.
Five therapies endorsed for use on NHS Scotland pharmatimes
July 09, 2018
A new treatment option for the very rare condition infantile onset 5q spinal muscular atrophy (type I SMA) is among five medicines that have been endorsed by Scottish cost regulators for use on the NHS.
Researcher uses HPV vaccine to treat patient with skin cancer europeanpharmaceuticalreview
July 05, 2018
Evidence suggests the human papillomavirus plays a role in the development of some types of this skin cancer…
Breakthrough badge for Novartis’ skin cancer combo pharmatimes
October 25, 2017
A targeted combination therapy being developed by Novartis as adjuvant treatment for patients with a certain type of melanoma has been assigned breakthrough designation in the US.
Topical treatment strategy for fighting skin cancer identified europeanpharmaceuticalreview
October 11, 2017
Researchers have combined low-intensity electric current with a formulation containing nano-encapsulated chemotherapy to treat skin cancer…
Medivir completes phase II clinical study of skin cancer therapy biospectrumasia
April 10, 2017
CTCL is a chronic, orphan hematologic cancer that presents in the skin
FDA approves first treatment for rare form of skin cancer worldpharmanews
March 27, 2017
The U.S. Food and Drug Administration has granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior ch
Piqur and Pierre Fabre announce partnership in dermato-oncology cphi-online
January 13, 2017
Collaboration will give Pierre Fabre the option to enter into exclusive negotiations to license global rights for the program in selected skin cancer conditions.

Previous page 1 2 3 Next page